Description
+ Include: 14 videos + 1 pdf, size: 3.78 GB
+ Target Audience: hematologist, oncologist
+ Sample video: contact me for sample video
+ Information:
OVERVIEW
LEARNING OBJECTIVES
- Discuss treatment options available for high risk MDS patients
- Examine new immune based therapies, including CAR T-cell therapy, in the treatment of multiple myeloma
- Describe therapeutic and molecular strategies for managing patients with Non-Hodgkin’s lymphoma
- Examine the management of older adult patients with AML
- Recognize some of the newer issues affecting the care of Hematology patients
TARGET AUDIENCE
This conference is designed specifically for hematologists, medical oncologists, pharmacists, pharmacy techs, fellows, advanced practice professionals, oncology nurses and other healthcare professionals who are interested in this field.
+ Topics:
FINAL.Heme-Conference-AGENDA-2024-v21.pdf
Hot Off the Press Lymphoid Diseases.mp4
Hot Off the Press Myeloid Diseases.mp4
Hot Off the Press Plasma Cell Dyscrasias.mp4
Lymphoid Malignancies Debate Harnessing the Immune System to Manage Relapsed Refractory Diffuse Large B Cell Lymphom No.mp4
Lymphoid Malignancies Debate Harnessing the Immune System to Manage Relapsed Refractory Diffuse Large B Cell Lymphom Yes.mp4
Lymphoid Malignancies Interactive Case Discussion Optimal Management of Patients with CLL.mp4
Lymphoid Malignancies State of the Art Frontline Treatment of Advanced Stage Hodgkin Lymphoma.mp4
Multiple Myeloma Debate Response-adapted approach to transplant in newly diagnosed MM are we there yet No.mp4
Multiple Myeloma Debate Response-adapted approach to transplant in newly diagnosed MM are we there yet Yes.mp4
Multiple Myeloma Interactive Case Discussion Optimal timing of CART-cell therapy in myeloma.mp4
Multiple Myeloma State of the Art Bi-specifics antibodies in myeloma Which How When.mp4
Myeloid Malignancies Debate- Worst of the worst- Should we transplant patients with p53 mutant MDS or AML Yes.mp4
Myeloid Malignancies Interactive Case Discussion- Optimal use of targeted therapy for the elderly or unfit AML patient.mp4
Myeloid Malignancies State of the Art- Making Sense of the New Classification Systems for MDS.mp4
Reviews
There are no reviews yet.